Used in pharmaceutical synthesis as a protected intermediate for developing bioactive molecules, particularly in the construction of nitrogen-containing heterocycles. The Boc and Cbz protecting groups allow selective manipulation of the amine functionality during multi-step reactions, making it valuable in the preparation of drug candidates targeting central nervous system disorders. Its seven-membered ring structure supports conformational studies in medicinal chemistry, aiding the design of receptor-targeted compounds. Commonly employed in solid-phase and solution-phase peptide-like synthesis where controlled deprotection and coupling are required.